Do Promises Outweigh the Perils Regarding the Use of Biosimilars in the Management of Macular Disease?

Authors

George Williams, Beaumont Health

Document Type

Conference Proceeding

Publication Date

8-26-2022

Recommended Citation

Williams G. Do promises outweigh the perils regarding the use of biosimilars in the management of macular disease? Presented at: 23rd Annual Advanced Vitreoretinal Techniques and Technology (AVTT) Symposium; 2022 Aug 26-28; Chicago, IL.

Comments

23rd Annual Advanced Vitreoretinal Techniques and Technology (AVTT) Symposium, August 26-28, 2022, Chicago, IL.